References
- Wei J, Chen F, Jin J, et al Novel influenza A (H1N1) in patients with hematologic disease. Leuk Lymphoma 2010;51:2079–2083.
- Patel P, Sweiss K, Shatavi S, Peace D, Clark N, Rondelli D. The impact of novel influenza A (H1N1) after hematopoietic SCT. Bone Marrow Transplant 2010 Mar 15. [Epub ahead of print].
- Seiter K, Nadelman RB, Liu D, Ahmed T, Montecalvo MA. Novel influenza A (H1N1) in patients with hematologic malignancies. J Clin Oncol 2010;28:e27–e29.
- Chemaly RF, Ghosh S, Bodey GP, et al Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Medicine (Baltimore) 2006;85:278–287.
- Elting LS, Whimbey E, Lo W, Couch R, Andreeff M, Bodey GP. Epidemiology of influenza A virus infection in patients with acute or chronic leukemia. Support Care Cancer 1995;3:198–202.
- Couch RB, Englund JA, Whimbey E. Respiratory viral infections in immunocompetent and immunocompromised persons. Am J Med 1997;102:2–9; discussion 25–26.
- Ljungman P. Respiratory virus infections in stem cell transplant patients: the European experience. Biol Blood Marrow Transplant 2001;7(Suppl.): 5S–7S.
- Jefferson T, Del Mar C, Dooley L, et al Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database Syst Rev 2010;(1):CD006207.
- Gooskens J, Jonges M, Claas EC, Meijer A, Kroes AC. Prolonged influenza virus infection during lymphocytopenia and frequent detection of drug-resistant viruses. J Infect Dis 2009;199:1435–1441.
- Pollyea DA, Brown JM, Horning SJ. Utility of influenza vaccination for oncology patients. J Clin Oncol 2010;28:2481–2490.
- Engelhard D, Nagler A, Hardan I, et al Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients. Bone Marrow Transplant 1993;11:1–5.
- Robertson JD, Nagesh K, Jowitt SN, et al Immunogenicity of vaccination against influenza, Streptococcus pneumoniae and Haemophilus influenzae type B in patients with multiple myeloma. Br J Cancer 2000;82:1261–1265.
- Izurieta HS, Haber P, Wise RP, et al Adverse events reported following live, cold-adapted, intranasal influenza vaccine. JAMA 2005;294:2720–2725.
- Moscona A. Neuraminidase inhibitors for influenza. N Engl J Med 2005;353:1363–1373.
- Ison M, Szakaly P, Shapira M, Krivan G, Nist A, Dutkowski R. Oseltamivir prophylaxis significantly reduces the incidence of seasonal influenza infection in immunocompromised patients. Paper presented at XI International Symposium on Respiratory Viral Infections. 19–22 February 2009. Bangkok, Thailand.
- Baz M, Abed Y, Papenburg J, Bouhy X, Hamelin ME, Boivin G. Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis. N Engl J Med 2009;361:2296–2297.